Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cryolife (CRY)

Cryolife (CRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 606,537
  • Shares Outstanding, K 39,081
  • Annual Sales, $ 276,220 K
  • Annual Income, $ 1,720 K
  • 60-Month Beta 0.86
  • Price/Sales 2.30
  • Price/Cash Flow 20.33
  • Price/Book 2.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.02
  • Number of Estimates 1
  • High Estimate 0.02
  • Low Estimate 0.02
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.63 +30.17%
on 03/23/20
25.85 -36.40%
on 03/02/20
-9.19 (-35.86%)
since 02/28/20
3-Month
12.63 +30.17%
on 03/23/20
31.77 -48.25%
on 01/29/20
-10.30 (-38.52%)
since 12/27/19
52-Week
12.63 +30.17%
on 03/23/20
33.00 -50.18%
on 07/31/19
-12.73 (-43.64%)
since 03/29/19

Most Recent Stories

More News
Downtrend Call Working As Cryolife Inc Stock Falls 46.7% (CRY)

SmarTrend identified a Downtrend for Cryolife Inc (NYSE:CRY) on February 14th, 2020 at $28.09. In approximately 1 month, Cryolife Inc has returned 46.73% as of today's recent price of $14.96.

CRY : 16.44 (+5.93%)
Global Valvular Heart Disease Treatment Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025

, a new addition to the catalog of Fior Markets, provides an overview of the current state of the market and its evolution. The report contains a forecast of 2019 and ending 2025 with key aspects such...

BSX : 31.64 (+3.36%)
CRY : 16.44 (+5.93%)
EW : 196.06 (-1.05%)
LIVN : 45.75 (+5.00%)
MDT : 92.05 (+2.40%)
NVCN.TO : 2.21 (-3.91%)
Catalyst Marketing Agency Wins CryoLife Business

Catalyst, a Denver marketing agency, today announced that they were selected by CryoLife, a biomedical company, for marketing services. The marketing services include design, content development and sales...

CRY : 16.44 (+5.93%)
CryoLife Receives CE Mark for E-vita Open NEO(TM) Hybrid Stent Graft

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-vita Open NEO, a hybrid stent graft system for...

CRY : 16.44 (+5.93%)
CryoLife Wins CE Mark, Boosts Mechanical Valve Foothold in EU

CryoLife's (CRY) On-X AAP completes the company's On-Xs heart valve portfolio.

MDT : 92.05 (+2.40%)
RMD : 154.21 (+8.64%)
CRY : 16.44 (+5.93%)
HRC : 101.58 (+2.06%)
% Return Seen to Date on SmarTrend Cryolife Inc Call (CRY)

SmarTrend identified a Downtrend for Cryolife Inc (NYSE:CRY) on February 14th, 2020 at $28.09. In approximately 2 weeks, Cryolife Inc has returned 8.74% as of today's recent price of $25.63.

CRY : 16.44 (+5.93%)
CryoLife Receives CE Mark for On-X® Ascending Aortic Prosthesis

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the On-X Ascending Aortic Prosthesis (AAP), allowing resumed...

CRY : 16.44 (+5.93%)
Noteworthy Tuesday Option Activity: CRY, IIPR, ZS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in CryoLife, Inc. , where a total volume of 1,525 contracts has been traded thus far today,...

CRY : 16.44 (+5.93%)
After Yesterday's Decline of 7.39%, Cryolife Inc Offers Investors Better Value

Cryolife Inc (NYSE:CRY) traded in a range yesterday that spanned from a low of $27.47 to a high of $29.03. Yesterday, the shares fell 7.4%, which took the trading range below the 3-day low of $29.92...

CRY : 16.44 (+5.93%)
CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results

https://mma.prnewswire.com/media/324116/cryolife__inc__logo.jpg

CRY : 16.44 (+5.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CRY with:

Business Summary

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical...

See More

Key Turning Points

2nd Resistance Point 17.36
1st Resistance Point 16.90
Last Price 16.44
1st Support Level 15.74
2nd Support Level 15.05

See More

52-Week High 33.00
Fibonacci 61.8% 25.22
Fibonacci 50% 22.82
Fibonacci 38.2% 20.41
Last Price 16.44
52-Week Low 12.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar